Alternative metabolic pathways for energy supply and resistance to apoptosis in Fanconi anaemia.

Deregulation of control of the apoptotic process in Fanconi anaemia (FA) appears to be one of the main features of this disease at the cellular level. We show here that FA cells are resistant to treatments with rhodamine-1,2,3 and doxycycline, which both interfere with mitochondrial functionality by different mechanisms. In contrast, normal lymphoblastoid cells are severely affected by these treatments, which result in acute ATP depletion and a significant enhancement of the fraction of cells undergoing apoptotic cell death. FA cells are very sensitive to the action of 2-deoxy-D-glucose (2dG) and iodoacetic acid (IAA), two inhibitors of glycolytic metabolism. The ability of FA cells to sustain metabolic insults interfering with energy production and balance may be linked with the pathological manifestations of the disease, including susceptibility to acute myeloid leukemia. These findings suggest that FA genes may be involved in a pathway that mediates a protective response to stress. We suggest that a peculiar metabolic regulation in FA cells could explain both defective apoptosis and susceptibility to oxidative stress.

[1]  V. Adleff,et al.  Apoptotic cell death induced by inhibitors of energy conservation--Bcl-2 inhibits apoptosis downstream of a fall of ATP level. , 1997, European journal of biochemistry.

[2]  E. Gordon-Smith,et al.  The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking , 1997, British journal of haematology.

[3]  S. Ganesan,et al.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. , 2001, Molecular cell.

[4]  C. Franceschi,et al.  The highly reducing sugar 2-deoxy-D-ribose induces apoptosis in human fibroblasts by reduced glutathione depletion and cytoskeletal disruption. , 1998, Biochemical and biophysical research communications.

[5]  E. Gordon-Smith,et al.  Increased apoptosis in aplastic anemia bone marrow progenitor cells: possible pathophysiologic significance. , 1995, Experimental hematology.

[6]  Rutherford,et al.  MOLECULAR GENETICS AND FANCONI ANAEMIA: NEW INSIGHTS INTO OLD PROBLEMS , 1998, British journal of haematology.

[7]  T. K. van den Berg,et al.  Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines. , 1996, Blood.

[8]  M. Brizzi,et al.  Production of interleukin 6, leukemia inhibitory factor and granulocyte‐macrophage colony stimulating factor by peripheral blood mononuclear cells in fanconi's anemia , 1993, Stem cells.

[9]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[10]  M. Raff,et al.  Constitutive expression of the machinery for programmed cell death , 1996, The Journal of cell biology.

[11]  C. Franceschi,et al.  Resistance to apoptosis in Fanconi's anaemia , 1997, FEBS letters.

[12]  R. Ashmun,et al.  The Fanconi anemia complementation group C protein corrects DNA interstrand cross-link-specific apoptosis in HSC536N cells. , 1996, Blood.

[13]  F. Rosselli,et al.  Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia , 1992, Human Genetics.

[14]  L. Romer,et al.  Mitochondrial dysfunction and cytoskeletal disruption during chemical hypoxia to cultured rat hepatic sinusoidal endothelial cells: The pH paradox and cytoprotection by glucose, acidotic pH, and glycine , 1998, Hepatology.

[15]  C. Guillouf,et al.  Fanconi anemia C protein acts at a switch between apoptosis and necrosis in mitomycin C-induced cell death. , 1999, Experimental cell research.

[16]  A. D’Andrea,et al.  Molecular biology of Fanconi anemia: implications for diagnosis and therapy. , 1997, Blood.

[17]  C. Franceschi,et al.  Mitochondria are selective targets for the protective effects of heat shock against oxidative injury. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. N. Spelbrink,et al.  Relationship between culture conditions and the dependency on mitochondrial function of mammalian cell proliferation , 1992, Journal of cellular physiology.

[19]  G. Singh,et al.  Accumulation of human promyelocytic leukemic (HL-60) cells at two energetic cell cycle checkpoints. , 1995, Cancer research.

[20]  I S Mian,et al.  The Fanconi anemia complementation group A protein contains a peroxidase domain. , 1998, Molecular genetics and metabolism.

[21]  D. Gustafson,et al.  A new cellular target for mitomycin C: a case for mitochondrial DNA. , 1997, Oncology research.

[22]  F. Rosselli,et al.  Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha. , 1994 .

[23]  E. Cundari,et al.  Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. , 1997, Cancer research.

[24]  D. Näf,et al.  The Fanconi anaemia proteins, FAA and FAC interact to form a nuclear complex , 1997, Nature Genetics.

[25]  K. Kannan,et al.  Oxidative stress and apoptosis. , 2000, Pathophysiology : the official journal of the International Society for Pathophysiology.